Understanding the cellular plasticity that enables urodeles to regenerate many tissues is important for determining why mammals repair those same tissues with scar. The answer may lie partly in a recently discovered differential responsiveness of urodele cells to factors present in serum at the wound site.
Mammals can regenerate some, but not all, tissues after wounding -for example, unlike some amphibians they cannot regenerate lost limbs. Mammalian tissues such as epithelia, blood, bone and muscle are continually or readily regenerated via stem or progenitor cells that are set aside for this purpose during fetal life. The central nervous system also has a limited regenerative capacity mediated by neural stem cells. The liver contains stem cells that are activated for regeneration only in cases of extreme damage; otherwise the liver regenerates by compensatory hyperplasia. But urodele amphibians -the salamanders and newts -can regenerate a number of tissues and complex structures that mammals cannot: lens, neural retina, spinal cord, upper and lower jaws, tails and limbs [1] . The unique feature underlying the regeneration of these structures is their ability to form a blastema of progenitor cells via the dedifferentiation of mature cells. The blastema grows and redifferentiates into exactly those parts that were damaged or lost.
Blastema formation by dedifferentiation has been best studied in regenerating urodele limbs. Amputation of the limb triggers the breakdown of extracellular matrix at the wound site, liberating fibroblasts, chondrocytes or osteocytes, myofibers and Schwann sheath cells from their tissue organization. Matrix degradation is achieved by the upregulation of proteases [2] [3] [4] [5] , particularly the acid hydrolases cathepsin D and acid phosphatase, and the matrix metalloproteinases (MMPs), particularly MMP-9 (gelatinase b), MMP-3/10a (stomelysin 1) and MMP-3/10b (stromelysin 2). Many light and electron microscope studies have suggested that the liberated cells lose their phenotypic specializations to become undifferentiated mesenchymal progenitor cells that re-enter the cell cycle and proliferate to form the regeneration blastema. Experiments in which labeled chondrocytes and myofibers were implanted into limb stumps or early regeneration blastemas have confirmed that these cell types dedifferentiate and become part of the blastema [1, 6] . Myofiber dedifferentiation is particularly interesting because these multinucleate cells must be broken up into undifferentiated mononucleate cells.
What endows the urodeles with this remarkable degree of cellular plasticity in the face of injury? There might be differences between urodeles and mammals in the molecular signals of the wound environment that allow cells (particularly fibroblasts) to proliferate, which in mammals divert them into pathways leading to scar tissue formation and in urodeles into pathways of dedifferentiation and regeneration. Alternatively, urodelean and mammalian wound environments might be similar, but the cellular responses to these environments might differ. Little information is available to support either hypothesis. In an important series of studies, Tanaka et al. [7] [8] [9] have used myotubes derived from cultured newt limb blastema cells to demonstrate that the plasticity of myofibers in regenerating newt limbs may be due in part to a unique ability to re-enter the cell cycle in response to wound factors.
In two previous papers, Tanaka et al. [7, 8] showed that serum from a variety of sources can stimulate cultured newt myotubes, but not mouse C2C12 myotubes, to reenter the cell cycle and synthesize DNA. In quiescent cells, an important suppressor of the cell cycle is the retinoblastoma protein, which binds to transcription factors that activate genes essential for cell-cycle entry, thus preventing them from acting. Growth factors, which are an important component of serum, can stimulate receptive cells to phosphorylate the retinoblastoma protein, releasing it from the transcription factors and sending the cell into S phase. This serum-stimulated phosphorylation of retinoblastoma protein is blocked in mouse myotubes, but not in newt myotubes. But a wide variety of growth factors that stimulate DNA synthesis in both newt and mouse myoblasts were unable to evoke DNA synthesis in newt myotubes. These results suggested that serum contains a different kind of factor that can stimulate DNA synthesis in newt myotubes, but not in mouse myotubes. Fractionation of serum yielded a crude fraction containing growth factors and thrombin -a crucial enzyme for plasma clotting -that had the stimulatory activity.
As reported recently in Current Biology, Tanaka et al. [9] have now shown directly that thrombin is the active component in this fraction that regulates cell-cycle re-entry (Figure 1) , and that thrombin activity is elevated early in newt limb regeneration. They were able to abolish the stimulatory activity of the crude thrombin fraction of serum by incubating it with thrombin inhibitors, such as hirudin. This fraction was further separable into two peaks, 1 and 2; peak 1 had the stimulatory activity, and further fractionation yielded pure thrombin. Using a fluorogenic thrombin substrate they were able to test, on cryostat sections of regenerating newt limbs, whether thrombin activity is elevated during the dedifferentiation stage: strong fluorescence was observed, which was abolished when the sections were incubated with a thrombin inhibitor.
Further experiments, however, showed that thrombin does not act directly on newt myotubes. Neither crude thrombin preparations nor pure thrombin elicited DNA synthesis unless serum was also present (Figure 1 ). Preparations in which serum at a subthreshold concentrationfor DNA synthesis -was incubated with thrombin for 24 hours before the addition of a thrombin inhibitor stimulated DNA synthesis, whereas incubation of the serum with both thrombin and inhibitor for 24 hours abolished the stimulatory activity. These results show that cell-cycle re-entry is stimulated not by thrombin directly, but indirectly through a serum protein that is activated by thrombin. This protein was shown to reside in peak 2 of the fractionated crude thrombin. Peak 2 retains 40% of the stimulatory activity of the crude thrombin fraction under serum-free conditions. Newt myotubes are thus clearly different from mammalian myotubes in being able to receive and transduce a signal provided by a thrombin-activated protein in serum that leads to cell-cycle re-entry and DNA synthesis. This protein is both necessary and sufficient to stimulate myotube nuclei to enter S phase. Work is underway to identify the protein -it is not any of the usual substrates of thrombin associated with blood clotting -whereupon it should be possible to determine its receptor(s) and perhaps the pathway involved in the signal transduction.
It should be noted that neither serum, the crude thrombin fraction, nor the factor activated by thrombin, is sufficient to drive newt myotube nuclei through mitosis; the nuclei remain arrested in G2 phase of the cell cycle. Both serum and the crude thrombin fraction promote complete cell cycling in myoblasts, but neither the peak 1 or 2 fractions have any effect on newt myoblasts. The action of the protein thus appears to be specific for newt myotubes, although possible effects on other mononucleate cells, such as fibroblasts, skeletal cells or Schwann cells, have not been tested. The data suggest that mammalian myotubes and newt and mammalian myoblasts do not respond to the protein, either because they lack the protein's receptor or because there is some factor in these cells that neutralizes the protein's activity.
Many questions remain about myofiber dedifferentiation in regenerating newt limbs. For example, what is the relationship between dedifferentiation and cell cycling in myofibers? Multinucleate myofibers are highly differentiated cells which, during regeneration in vivo, break up into mononucleate cells. Myofiber break up and dedifferentiation are clearly not required for the protein identified by Tanaka et al. [9] to stimulate myotube nuclei to enter S phase, but are they required for the completion of myonuclear mitosis? Is there a mechanistic link between myofiber break up, dedifferentiation and the ability to traverse G2 phase and form a mitotic spindle? How is the myofiber broken up into mononucleate cells? Is the protein identified by Tanaka et al. [9] sufficient to induce complete mitosis once mononucleate cell status has been attained? Is further proliferation then under the control of the growth and trophic factors supplied by the limb nerves and wound epidermis [1, 6] ? Is entry of myofibers -or other cell types for that matter -into S phase prior to dedifferentiation the rule in regenerating newt limbs?
Finally, like mammals, the bones and muscles of the urodele limb contain reserve osteogenic cells and myoblasts Identification of a protein in serum that stimulates nuclei of newt myotubes, but not those of mouse myotubes or mononucleate cells of either newt or mouse, to re-enter the cell cycle, in particular to progress to S phase (and thus undergo DNA replication). The crude thrombin fraction of serum (far left) was fractionated into two peaks, 1 and 2. Peak 1 was further fractionated to yield pure thrombin, which when incubated with serum produces an active protein that stimulates DNA synthesis in newt myotubes, but not in mouse myotubes or mononucleate cells. Peak 2 contains the active protein, which stimulates DNA synthesis in newt myotubes in the absence of serum.
(satellite cells). These cells are activated, proliferate and regenerate new tissue after a local injury [1] . Although a contribution of such reserve progenitor cells to the regeneration blastema has not been ruled out, it is an interesting question why the blastema seems to be derived primarily from the dedifferentiation of mature cells. Perhaps the sheer number of cells required to regenerate a limb is more than can be supplied by proliferation of reserve cells alone. Or perhaps reserve cells do not have a memory of their position in the limb that dermal fibroblasts and muscle cells are known to have stamped upon them during embryogenesis [10] , so that dedifferentiated cells carrying that memory are essential for the regeneration of the complex tissue pattern of the limb. Whatever the case, the intrinsic properties of urodele cells that endow them with their regenerative plasticity deserve more attention; understanding the basis of these properties may suggest show similar plasticity might be conferred on mammalian cells.
